Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
2008 ◽
Vol 30
(3)
◽
pp. 499-512
◽
2009 ◽
Vol 25
(10)
◽
pp. 2361-2371
◽
2011 ◽
Vol 33
(7)
◽
pp. 973-989
◽
2006 ◽
Vol 28
(10)
◽
pp. 1556-1568
◽
2016 ◽
Vol 18
(5)
◽
pp. 528-532
◽
2018 ◽
Vol 138
◽
pp. 253-261
◽
2007 ◽
Vol 39
(3)
◽
pp. 218-223
◽
Keyword(s):
2017 ◽
Vol 19
(5)
◽
pp. 635-643
◽
2014 ◽
Vol 2
(2)
◽
pp. 125-132
◽